Ozawa, Tadashi
Suzuki, Hiroko
Miyata, Takahiro
Kameda, Tomoaki
Kobari, Takashi
Tetsuka, Masayuki
Arai, Fumihiro
Ohtani, Keisuke
Miyawaki, Takahiro
Nagai, Mutsumi
Hashimoto, Masaaki
Fujiwara, Takeshi
Kario, Kazuomi
Kawai, Kensuke
Fujimoto, Shigeru
Tanaka, Ryota
Article History
Received: 9 June 2024
Revised: 18 December 2024
Accepted: 22 December 2024
First Online: 10 January 2025
Compliance with ethical standards
:
: TK received lecture fees from Daiichi-Sankyo Pharmaceutical. KK received a study grants or contracts from Eisai, Daiichi-Sankyo Pharmaceutical, and E.P. medical, consulting fees from Zimmer Biomet, Ono Pharmaceutical, Viatris Pharmaceutical, and IQVIA, and lecture fees and speaker’s fees from Eisai and Daiichi-Sankyo Pharmaceutical. SF received lecture fees and speaker’s fees from Daiichi-Sankyo Pharmaceutical, Bayer Pharmaceutical, Bristol-Myers Squibb, Nippon Boehringer Ingelheim, and Pfizer Japan. RT received lecture fees and speaker’s fees from Nippon Boehringer Ingelheim, Takeda Pharmaceutical, CSL Behring, Eisai, Kowa, Daiichi-Sankyo Pharmaceutical, Kyowa Kirin, Bayer Pharmaceutical, Bristol-Myers Squibb, Otsuka Pharmaceutical, Pfizer Japan, and AbbVie GK.